Ascendant Health / Genesis Life Sciences is a life sciences. Over the past three years, Ascendant Health / Genesis Life Sciences has been involved in 1 licensing and acquisition transaction, with a primary focus on Antibodies (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Antibodies
Focus Area
Dermatology
Licensing, acquisition, and partnership transactions involving Ascendant Health / Genesis Life Sciences in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Ascendant-221 / CUE-221 | Cue Biopharma | Antibodies | Phase 2 | license | Apr 30, 2026 |
Therapeutic areas and modalities where Ascendant Health / Genesis Life Sciences is most active based on deal history and clinical trial data.
Use Solidus to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
Ascendant Health / Genesis Life Sciences is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Ascendant Health / Genesis Life Sciences ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Ascendant Health / Genesis Life Sciences include Dermatology (2 deals and trials). In terms of modality, Ascendant Health / Genesis Life Sciences has shown particular interest in antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Ascendant Health / Genesis Life Sciences and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Ascendant Health / Genesis Life Sciences's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.